ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predictive Biomarker in Adjuvant Chemo in Patients With Stage II Colon Cancer"

199 views
February 1, 2024
0 Comments
Login to view comments. Click here to Login